What Phase 3 data supports the research relevance of Retatrutide
Semaglutide is the active ingredient in two FDA-approved prescription medications: Ozempic, approved for improving blood sugar control in adults with type 2 diabetes, and Wegovy, approved for chronic weight management in adults with obesity or overweight who have at least one weight-related medical condition
for 2-3 months plans Tirzepatide ($279/mo for 3 months, Starting dose of 2.5 mg $99/mo Insurance Subject to insurance approval* Use for Zepbound and Wegovy requests Personalized nutrition plans Workout plans Medication costs included Pharmacy determines co-pay Lose weight in 3 simple steps Complete your virtual visit over video Discuss your weight loss goals during your telehealth visit
Sherman MH, Yu RT, Tseng TW, Sousa CM, Liu S, Truitt ML, He N, Ding N, Liddle C, Atkins AR, et al